Skip to main content

ScienceDex / Researcher record

Vanveldhuisen, Paul

From the FY2022 NIH awards this investigator leads as contact PI. The department is the award's.

FY2022 NIH rank #3,346
  • Sustained Excellence
  • Long-Funded

NIH Funding · FY2022

$2.1M
Full award amounts, FY2022
4
Records listing this PI
#3,346
By linked amount among FY2022 PIs
2007
ScienceDex PI coverage

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

Linked awards ($M)Award-linked rank
View yearly values
Award-linked funding and rank by fiscal year
Fiscal yearLinked awardsRecordsRank
2007$2,588,5471#1,741
2011$4,011,1441#952
2012$3,956,0811#928
2013$3,368,8941#1,144
2014$3,378,7261#1,241
2015$3,499,8991#1,152
2016$3,582,9791#1,042
2017$3,733,0191#895
2018$3,219,5571#1,243
2019$14,197,67410#104
2021$9,597,0349#256
2022$2,101,0824#3,346

Award activity

Awards through the years

NIH award records listing this researcher in each fiscal year.

  1. FY20071 record
  2. FY20111 record
  3. FY20121 record
  4. FY20131 record
  5. FY20141 record
  6. FY20151 record
  7. FY20161 record
  8. FY20171 record
  9. FY20181 record
  10. FY201910 records
  11. FY20219 records
  12. FY2022 · selected4 records

Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Vanveldhuisen, Paul. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2025 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets About this stat →

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Publications

Loading publications…

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID unavailableSearch this ID in NIH RePORTER
ORCID iD
No ORCID iD on recordA researcher can add one by claiming this profile.
ScienceDex PI coverage
FY2007 through FY2022Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.

FY2022 award records by amount

NIH award records listing Vanveldhuisen, Paul as a PI. Multi-PI records show the full award amount for context.

  • 75N95019D00013-P00002-759502000002-1N01Contact PI
    OPTIMIZING RETENTION, DURATION&DISCONTINUATION STRATEGIES FOR OPIOID USE DISORDER PHARMACOTHERAPY (CTN-0100). 03/01/2020 - 08/15/2022. N01DA-19-2250.T
    $1.4M
    award amount
  • 75N95019D00013-P00001-759501900095-1N01Contact PI
    EMERGENCY DEPARTMENT-INITIATED BUPRENORPHINE AND VALIDATION NETWORK TRIAL (CTN-0099). DSC5 CONTRACT. 09/20/2019 - 11/12/2022. N01DA-19-2250.
    $490.3K
    award amount
  • 75N95019D00013-P00003-759501900097-1N01Contact PI
    SUBTHRESHOLD OPIOID USE DISORDER PREVENTION TRIAL (CTN-0101). DSC5 CONTRACT. 09/20/2019 - 11/16/2020. N01DA-19-2250.
    $245.2K
    award amount
  • 75N95019D00013-P00001-759502000003-1N01Contact PI
    ADOLESCENT SCREENING TO HELP ELIMINATE MISUSE (CTN-0060-A-1). 8/1/2020 - 12/31/2021. N01DA-19-2250. TASK ORDER 75N95020F00003 (TO14).
    $15K
    award amount

Award organization

Organizations that administered FY2022 awards listing Vanveldhuisen, Paul as a PI.

FY2022 award administered by The Emmes Company, LLC (MD).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2007
    First NIH Award
    The Emmes Company, LLC
  2. 2007
    $500K Cumulative Funding
  3. 2007
    $1M Cumulative Funding
  4. 2007
    $2M Cumulative Funding
  5. 2007
    Entered Top 50% Nationally
    Ranked #1741
  6. 2007
    Entered Top 25% Nationally
    Ranked #1741
  7. 2007
    Entered Top 10% Nationally
    Ranked #1741
  8. 2011
    $5M Cumulative Funding
  9. 2011
    Entered Top 5% Nationally
    Ranked #952
  10. 2012
    $10M Cumulative Funding
  11. 2017
    $25M Cumulative Funding
  12. 2019
    Entered Top 1% Nationally
    Ranked #104
  13. 2021
    $50M Cumulative Funding